Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Freeman

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism|June 20, 2025
Outcomes of recombinant growth hormone therapy in the traumatic brain injury population: A scoping reviewRichard D Batson, Joshua Z Goldenberg, Ryan S Wexler, et al.
Journal of the American College of Cardiology|November 13, 2007
F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2)Rob S B Beanlands, Graham Nichol, Ella Huszti, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 22, 2013
Cost-effectiveness of 64-slice CT angiography compared to conventional coronary angiography based on a coverage with evidence development study in OntarioRon Goeree, Gord Blackhouse, James M Bowen, et al.
Journal of the American College of Cardiology|November 26, 2002
Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular functionRob S B Beanlands, Terrence D Ruddy, Robert A deKemp, et al.
JACC. Cardiovascular Imaging|September 19, 2009
Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trialGianni D'Egidio, Graham Nichol, Kathryn A Williams, et al.
Journal of Virology|January 8, 2010
Breadth of neutralizing antibodies elicited by stable, homogeneous clade A and clade C HIV-1 gp140 envelope trimers in guinea pigsJoseph P Nkolola, Hanqin Peng, Ethan C Settembre, et al.
Dermatology and Therapy|November 22, 2019
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of ExposureApril Armstrong, Carle Paul, Luis Puig, et al.
International Journal of Dermatology|January 13, 2010
Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studiesPeter Foley, Michael Freeman, Alan Menter, et al.
The Canadian Journal of Cardiology|December 6, 2011
Does FDG PET-assisted management of patients with left ventricular dysfunction improve quality of life? A substudy of the PARR-2 trialTushar Shukla, Graham Nichol, George Wells, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 6, 2021
A Participant-Centered Approach to Understanding Risks and Benefits of Participation in Research Informed by the Kidney Precision Medicine ProjectCatherine R Butler, Paul S Appelbaum, Heather Ascani, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Best Practice & Research. Clinical Endocrinology & Metabolism|June 20, 2025
Outcomes of recombinant growth hormone therapy in the traumatic brain injury population: A scoping reviewRichard D Batson, Joshua Z Goldenberg, Ryan S Wexler, et al.
Journal of the American College of Cardiology|November 13, 2007
F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2)Rob S B Beanlands, Graham Nichol, Ella Huszti, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 22, 2013
Cost-effectiveness of 64-slice CT angiography compared to conventional coronary angiography based on a coverage with evidence development study in OntarioRon Goeree, Gord Blackhouse, James M Bowen, et al.
Journal of the American College of Cardiology|November 26, 2002
Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular functionRob S B Beanlands, Terrence D Ruddy, Robert A deKemp, et al.
JACC. Cardiovascular Imaging|September 19, 2009
Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trialGianni D'Egidio, Graham Nichol, Kathryn A Williams, et al.
Journal of Virology|January 8, 2010
Breadth of neutralizing antibodies elicited by stable, homogeneous clade A and clade C HIV-1 gp140 envelope trimers in guinea pigsJoseph P Nkolola, Hanqin Peng, Ethan C Settembre, et al.
Dermatology and Therapy|November 22, 2019
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of ExposureApril Armstrong, Carle Paul, Luis Puig, et al.
International Journal of Dermatology|January 13, 2010
Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studiesPeter Foley, Michael Freeman, Alan Menter, et al.
The Canadian Journal of Cardiology|December 6, 2011
Does FDG PET-assisted management of patients with left ventricular dysfunction improve quality of life? A substudy of the PARR-2 trialTushar Shukla, Graham Nichol, George Wells, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 6, 2021
A Participant-Centered Approach to Understanding Risks and Benefits of Participation in Research Informed by the Kidney Precision Medicine ProjectCatherine R Butler, Paul S Appelbaum, Heather Ascani, et al.
Pageof 12